Technical analysis of Ainos, Inc. (AIMD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications.
Price Performance
| 1 month | -1.43% |
| 3 months | -24.59% |
| Year-to-date | -15.85% |
| 1 year | -59.77% |
| 3 years | -91.88% |
| 5 years | -99.39% |
52-Week Range
| 52-week High | $4.44 |
| 52-week Low | $1.26 |
| Avg Volume (90d) | 303K |
Technical Indicators
| SMA 50 | $1.50 |
| SMA 200 | $1.74 |
| Beta | 2.32 |
| 30-day Volatility (annualised) | 61.3% |
| Price vs SMA 50 | -8.3% |
| Price vs SMA 200 | -20.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.30 | |
| 2025-11 | $2.10 | -36.4% |
| 2025-12 | $1.64 | -21.9% |
| 2026-01 | $2.00 | +22.0% |
| 2026-02 | $1.64 | -18.0% |
| 2026-03 | $1.39 | -15.2% |
| 2026-04 | $1.74 | +25.2% |
| 2026-05 | $2.38 | +36.8% |
| 2026-06 | $1.94 | -18.5% |
| 2026-07 | $1.33 | -31.4% |
| 2026-08 | $1.40 | +5.3% |
| 2026-09 | $1.38 | -1.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.38 |
| Market Cap | $10M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.82 |
| EV / EBITDA | -2.60 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 4.21 |
| Current Ratio | 0.13 |